Patents by Inventor Shugo Honda

Shugo Honda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused ring pyridine compound
    Patent number: 8791106
    Abstract: [Problem] To provide a compound useful as a novel agent which is excellent in preventing and/or treating cannabinoid receptor type 2-related diseases, based on agonist action on a cannabinoid receptor type 2 [Means for Solution] The present inventors conducted thorough investigation regarding compounds having agonist action on a cannabinoid receptor type 2. They confirmed that the fused ring pyridine compound of the present invention has excellent agonist action on the cannabinoid receptor type 2, thereby completing the present invention. The fused ring pyridine compound of the present invention has agonist action on the cannabinoid receptor type 2, and can be used as an agent for preventing and/or treating cannabinoid receptor type 2-related diseases, for example, inflammatory diseases and pain.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: July 29, 2014
    Assignee: Astellas Pharma Inc.
    Inventors: Yuji Matsushima, Minoru Kameda, Shugo Honda, Yukihito Sugano, Hiroyuki Usuda, Tadashi Terasaka, Takeshi Terasawa, Fusako Nishigaki
  • Melanocortin receptor agonists
    Patent number: 7989634
    Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: August 2, 2011
    Assignees: LG Life Sciences Ltd., Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Koo Lee, Heui-Sul Park, In-Ae Ahn, Hyun-Ju Yoo, Jong-Yup Kim, Deog-Young Choi, Hyeon-Joo Yim, Kyung-Ha Chung, Dong-Sup Shim, Sang-Kyun Lee, Yutaka Kondoh, Ryoji Hirabayashi, Shugo Honda, Hidetaka Kaku, Jun-ichi Shishikura, Hiroyuki Ito, Takeshi Kurama
  • Melanocortin receptor agonists
    Publication number: 20070129346
    Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Application
    Filed: November 12, 2004
    Publication date: June 7, 2007
    Applicants: LG Life Sciences Ltd., Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Koo Lee, Heui-Sul Park, In-Ae Ahn, Hyun-Ju Yoo, Jong-Yup Kim, Deog-Young Choi, Hyeon-Joo Yim, Kyung-Ha Chung, Dong-Sup Shim, Sang-Kyun Lee, Yutaka Kondoh, Ryoji Hirabayashi, Shugo Honda, Hidetaka Kaku, Jun-ichi Shishikura, Hiroyuki Ito, Takeshi Kurama